Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751737 · ClinicalTrials.gov registry record · NA
Choline PET/CT and MRI for Targeted Prostate Biopsy
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT01751737 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 63 participants.
The verdict
NCT01751737, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
This research study will access the using of a radiotracer, 18F-choline PET/CT and MRI for prostate cancer in patients undergoing diagnostic prostate biopsy. Patients receive MRI guided prostate biopsies and metabolomic profiling of prostate biopsy tissues.
Interventions
- PROCEDURE Prostate Cancer Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01751737
The ClinicalTrials.gov registry entry for NCT01751737 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prostate Cancer Imaging is the first listed.
NCT01751737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01751737 about?
NCT01751737 is a clinical study titled "Choline PET/CT and MRI for Targeted Prostate Biopsy". This research study will access the using of a radiotracer, 18F-choline PET/CT and MRI for prostate cancer in patients undergoing diagnostic prostate biopsy. Patients receive MRI guided prostate biopsies and metabolomic profiling of prostate biopsy tissues.
What is the current status of trial NCT01751737?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2012-11. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01751737?
The interventions under investigation include: Prostate Cancer Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01751737?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.